LONDON, UK — 4th March 2025, – Live from World EPA Congress in Amsterdam, Access Infinity is excited to announce the launch of JCA Navigator, an innovative, AI-powered solution designed to help pharmaceutical companies successfully navigate the EU’s evolving Joint Clinical Assessment (JCA) framework.
JCA Navigator enables organisations to proactively manage clinical evaluations, streamline evidence generation, and optimise market access strategies in this new and evolving regulatory landscape.
Commenting on the launch of the tool, Keshav Nagaraja, Managing Director – Digital, at Access Infinity said:
JCA Navigator is designed to help value, access and pricing teams overcome the following challenges:
- Predicting JCA Requirements: AI-driven analytics forecast likely PICO scenarios based on historical HTA data.
- Streamlining Evidence Generation: Automated data synthesis from multiple sources.
- Optimising Cross-Market Analysis: Compare competitor outcomes for strategic planning and decision making.
- Facilitating Collaboration and Communication: Consolidates data for unified team views and alignment.
- Reducing Resource Strain: AI automation minimises manual efforts, freeing up resources for high-value strategic initiatives.
The Access Infinity team is showcasing JCA Navigator throughout this year’s World EPA Congress, Amsterdam from 5th – 6th March. To find out more and see the solution in action, visit the team at Booth 1.
Related resources:
Read more about AI’s role in preparing for JCA in our blog: accessinfinity.com/blogs/preparing-for-jca-ai-could-be-the-key-to-pharmas-success-in-the-eus-hta-framework/
Founded in 2014, Access Infinity exists to help pharma companies overcome market access challenges. The company began as a consulting firm to guide pharma businesses in developing and implementing effective market access and pricing strategies and continues to be a leader in the space. It has since introduced market-redefining digital tools, NUROTM, Access HubTM and Evidence Hub to help market access teams work smarter, faster, and more efficiently with valuable insights at their fingertips.
With offices in London, Hyderabad, New York and Manchester, Access Infinity is experiencing rapid growth as it continues to transform and simplify market access for pharmaceutical organisations globally. Clients include many of the pharmaceutical industry’s most influential companies such as AstraZeneca, J&J, MSD, GSK and Pfizer. In 2023 Access Infinity received a Bronze Stevie® Award in the Technical Innovation of the Year category for organisations with up to 100 employees. The business was also recognised in GHP magazine’s Healthcare & Pharmaceutical Awards, winning “Most innovative digital pharmaceuticals platform 2023 UK”.
For media enquiries, please contact:
Email: louise@accessinfinity.com
Tel: +44 (0)20 4583 5450
